Riskpilot← Back to searchSign inGet full accessANDERSEN BIOTECH AS
ASActiveOrg 911628090Stordamveien 60B, 0671 OsloBusiness and other management consultancy activities · NACE 7020Est. 20130 employees
Revenue 2024
NOK 0
EBITDA margin
—
-87% vs 2023
Equity ratio
-8.8%
Financial strength
Net profit 2024
NOK -274K
-104% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -304K | -87% |
| Net profit | NOK -274K | -104% |
| Total assets | NOK 1M | -86% |
| Equity | NOK -91K | -150% |
| Employees | 0 | — |
Legal name
ANDERSEN BIOTECH AS
Org number
911628090
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
27. februar 2013
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fremstilling/salg av løsninger innen bioteknologi, konsulenttjenester og andre produkter /tjenester som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Stordamveien 60B, 0671 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 391 | 1 420 | 1 495 | 1 472 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −1 287 | −1 523 | −1 572 | −1 094 | −47 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 606 | −354 | −232 | 266 | −41 | −87 | 73 | −14 | −12 | −23 | −163 | −304 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 606 | −354 | −232 | 266 | −41 | −87 | 73 | −14 | −12 | −23 | −163 | −304 |
| Net financials | 0 | −9 | −8 | −11 | −23 | −24 | −27 | −27 | 7 850 | −8 | 6 799 | 30 |
| Profit before tax | 606 | −363 | −240 | 256 | −64 | −112 | 47 | −42 | 7 839 | −31 | 6 636 | −274 |
| Tax | 180 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 426 | −363 | −240 | 256 | −64 | −112 | 47 | −42 | 7 839 | −31 | 6 636 | −274 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 065 | 238 | −23 | 237 | −24 | 60 | 143 | 143 | 7 789 | 758 | 7 397 | 1 035 |
| Equity | 256 | −107 | −346 | −91 | −155 | −266 | −220 | −261 | 577 | 546 | 182 | −91 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 809 | 344 | 324 | 328 | 131 | 326 | 362 | 404 | 7 211 | 211 | 7 214 | 1 126 |
| Total debt | 809 | 344 | 324 | 328 | 131 | 326 | 362 | 404 | 7 211 | 211 | 7 214 | 1 126 |
EBITDA margin
-30392800.0%
This company
15.8%
Market median
-192359594% vs market
20132024
Equity ratio
-8.8%
This company
38.2%
Market median
-123% vs market
20132024
Return on equity
-27355200.0%
This company
18.4%
Market median
-148669665% vs market
20132024
Net profit margin
-27355200.0%
This company
8.1%
Market median
-337718619% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
12.36×
This company
0.62×
Market median
-1894% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Deputy Member | Deputy Member | 2013 | — | — |
EA Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANDERSEN BIOTECH AS 
Antec Biogas AsBoard members of ANDERSEN BIOTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jeanette Hafnor | Deputy Member | 0 companies |
| Egil Andersen | Chief Executive Officer | 0 companies |